The WHO’s cancer agency’s designation for hairstylists does not extend to people who dye their hair. That remains “not ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

Many gynecological cancer patients face barriers to treatment and support. This Westchester woman helped uncover the gaps and seek solutions.

Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...